Mercer Global Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.61M Sell
51,373
-1,488
-3% -$274K 0.01% 581
2026
Q1
$9.98M Buy
52,861
+10,681
+25% +$2.25M 0.01% 499
2025
Q4
$8.38M Buy
42,180
+8,273
+24% +$1.67M 0.01% 543
2025
Q3
$6.88M Buy
33,907
+12,596
+59% +$2.23M 0.01% 564
2025
Q2
$3.75M Buy
21,311
+14,035
+193% +$2.11M 0.01% 659
2025
Q1
$979K Buy
7,276
+1,652
+29% +$218K ﹤0.01% 1159
2024
Q4
$710K Sell
5,624
-786
-12% -$117K ﹤0.01% 1262
2024
Q3
$1.04M Buy
6,410
+114
+2% +$17.2K ﹤0.01% 1004
2024
Q2
$905K Buy
+6,296
New +$758K ﹤0.01% 1011

Other funds holding THC

Mercer Global Advisors's THC Position: Q2 2026 in Review

Mercer Global Advisors reduced its Tenet Healthcare (THC) stake by 2.8% in Q2 2026, selling an estimated $274K and leaving 51,373 shares worth $9.61M. The position accounts for 0.01% of the portfolio, ranked #581.

Mercer Global Advisors first reported a position in THC in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.98M in Q1 2026. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Mercer Global Advisors held 51,373 shares of Tenet Healthcare worth $9.61M as of Q2 2026.
  • Mercer Global Advisors sold 1,488 Tenet Healthcare shares in Q2 2026, an estimated $274K.
  • Tenet Healthcare made up 0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #581 holding.
  • Mercer Global Advisors first reported a position in Tenet Healthcare in Q2 2024 and has held it in 9 quarters since.
  • Mercer Global Advisors's Tenet Healthcare position peaked at $9.98M in Q1 2026.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.